MindBio Therapeutics Corp.
MBIO
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 420.22% | 503.01% | -58.74% | -54.59% | -94.76% |
| Total Receivables | 3,129.83% | 74.52% | -14.39% | -7.30% | -29.79% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2,392.35% | 299.66% | -34.97% | -41.13% | -83.93% |
|
|
|||||
| Total Current Assets | 2,392.35% | 299.66% | -34.97% | -41.13% | -83.93% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2,377.20% | 299.66% | -34.97% | -41.13% | -83.83% |
|
|
|||||
| Total Accounts Payable | -75.65% | -66.96% | -73.05% | -28.31% | 38.14% |
| Total Accrued Expenses | 55.11% | 52.32% | 76.04% | 81.46% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -50.61% | -52.18% | -56.50% | -55.77% | 342.71% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -52.39% | -52.43% | -56.37% | -52.48% | 248.22% |
|
|
|||||
| Total Current Liabilities | -52.39% | -52.43% | -56.37% | -52.48% | 248.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -15.16% |
| Total Liabilities | -54.81% | -54.85% | -58.67% | -55.11% | -1.44% |
|
|
|||||
| Common Stock & APIC | 201.47% | 208.17% | 106.16% | 91.41% | 16.37% |
| Retained Earnings | -63.10% | -54.67% | -22.94% | -20.30% | -7.17% |
| Treasury Stock & Other | 23.01% | -56.20% | 34.29% | 32.26% | -8.91% |
| Total Common Equity | 76.88% | 64.12% | 59.74% | 56.27% | -3.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 76.88% | 64.12% | 59.74% | 56.27% | -3.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -19.67% | -15.25% | -8.72% | -9.80% | -10.24% |
| Total Equity | 75.94% | 63.36% | 59.11% | 55.61% | -3.13% |
|
|
|||||